VRSK(VRSK)
VRSK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $3.22B | $3.44B | $3.67B | $3.93B | $4.21B |
| Low | $3.21B | $3.40B | $3.66B | $3.90B | $4.18B |
| High | $3.24B | $3.47B | $3.67B | $3.97B | $4.25B |
| EBITDA Avg | $1.86B | $1.98B | $2.11B | $2.27B | $2.43B |
| Low | $1.85B | $1.96B | $2.11B | $2.25B | $2.41B |
| High | $1.87B | $2.00B | $2.11B | $2.28B | $2.45B |
| EBIT Avg | $1.47B | $1.57B | $1.67B | $1.79B | $1.92B |
| Low | $1.46B | $1.55B | $1.67B | $1.78B | $1.90B |
| High | $1.48B | $1.58B | $1.67B | $1.81B | $1.93B |
| Net Income Avg | $1.06B | $1.20B | $1.33B | $1.53B | $1.72B |
| Low | $1.04B | $1.16B | $1.26B | $1.51B | $1.70B |
| High | $1.08B | $1.25B | $1.40B | $1.54B | $1.74B |
| EPS Avg | $7.67 | $8.68 | $9.74 | $10.97 | $12.35 |
| Low | $7.51 | $8.34 | $9.04 | $10.85 | $12.22 |
| High | $7.77 | $8.95 | $10.05 | $11.08 | $12.48 |
| Analysts (Rev / EPS) | 13 / 13 | 13 / 13 | 10 / 7 | 5 / 2 | 5 / 5 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $804M | $812M | $825M | $835M | $858M | $865M | $879M | $896M |
| Low | $797M | $807M | $819M | $828M | $852M | $858M | $873M | $889M |
| High | $810M | $817M | $836M | $845M | $869M | $875M | $890M | $907M |
| EBITDA Avg | $463M | $468M | $475M | $481M | $494M | $498M | $507M | $516M |
| Low | $459M | $465M | $472M | $477M | $491M | $494M | $503M | $512M |
| High | $467M | $471M | $481M | $487M | $501M | $504M | $513M | $523M |
| EBIT Avg | $366M | $370M | $376M | $380M | $391M | $394M | $400M | $408M |
| Low | $363M | $368M | $373M | $377M | $388M | $391M | $397M | $405M |
| High | $369M | $372M | $381M | $385M | $396M | $399M | $405M | $413M |
| Net Income Avg | $262M | $264M | $268M | $279M | $295M | $297M | $302M | $312M |
| Low | $255M | $260M | $266M | $277M | $292M | $294M | $299M | $309M |
| High | $268M | $268M | $273M | $284M | $300M | $301M | $307M | $317M |
| EPS Avg | $1.94 | $1.95 | $1.98 | $2.07 | $2.18 | $2.19 | $2.23 | $2.31 |
| Low | $1.89 | $1.92 | $1.96 | $2.04 | $2.16 | $2.17 | $2.21 | $2.28 |
| High | $1.98 | $1.98 | $2.02 | $2.10 | $2.22 | $2.23 | $2.27 | $2.34 |
| Analysts (Rev / EPS) | 10 / 12 | 10 / 11 | 5 / 4 | 5 / 4 | 5 / 5 | 5 / 8 | 5 / 4 | 4 / 5 |